SCHEMBL30926893

SCHEMBL30926893

O=C(Nc1cccc(S(=O)(=O)Nc2ccccc2F)c1)c1ccsc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.59
▸ MAPT P10636 7/20 0.59
▸ MEN1 O00255 7/20 0.59
▸ ALDH1A1 P00352 6/20 0.59
▸ APOBEC3G Q9HC16 4/20 0.59
▸ MAPK1 P28482 4/20 0.59
▸ GRM4 Q14833 2/20 0.59
▸ LMNA P02545 4/20 0.57
▸ HPGD P15428 3/20 0.57
▸ PKM P14618 1/20 0.57
▸ MPI P34949 1/20 0.57
▸ KCNK3 O14649 1/20 0.56
▸ KCNK9 Q9NPC2 1/20 0.56
▸ POLB P06746 1/20 0.55
▸ NPY1R P25929 1/20 0.55
▸ NPY2R P49146 1/20 0.55
▸ IDH2 P48735 1/20 0.52
▸ KDM4E B2RXH2 2/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180073 1.00 KMT2A (0.59) KMT2AMAPTMEN1ALDH1A1APOBEC3G
SCHEMBL30926895 0.81 MEN1 (0.60) KMT2AMAPTMEN1ALDH1A1APOBEC3G
SCHEMBL20063247 0.81 MEN1 (0.60) KMT2AMAPTMEN1ALDH1A1APOBEC3G
SCHEMBL27179831 0.80 KMT2A (0.65) KMT2AMAPTMEN1MAPK1GRM4
SCHEMBL30926691 0.80 KMT2A (0.67) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL27180407 0.80 KMT2A (0.67) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL30926888 0.80 KMT2A (0.65) KMT2AMAPTMEN1MAPK1GRM4
SCHEMBL30926540 0.80 IDH2 (0.61) KMT2AMAPTMEN1ALDH1A1LMNA
SCHEMBL27180226 0.80 IDH2 (0.61) KMT2AMAPTMEN1ALDH1A1LMNA
SCHEMBL30926950 0.77 RXFP1 (0.64) KMT2AMAPTMEN1ALDH1A1APOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP KMT2A 2544/4885MAPT 4236/4885MEN1 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback